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Delineation of the complex events involved in requisite cooperative interac- 
tions between thymus-derived (T) and bone marrow-derived (B) lymphocytes 
in the development of antibody responses to all but a selected class of antigens 
has been the subject of intensive analysis in many laboratories  (reviewed in 
reference 1). A major effort in this regard has been focused on the identifica- 
tion of various biologically active substances capable of influencing lymphocyte 
function on  antibody responses  to different antigens elicited in in vitro  sys- 
tems. Such studies have utilized either a variety of mitogenic substances  origi- 
nating from sources other than lymphocytes (reviewed in reference 2)  or  sub- 
stances generated during lymphocyte activation, and presumably lymphocyte 
derived, in the course of in vitro cell responses to either mitogens, antigens,  or 
both (3-21). 
The  demonstration by Dutton et  al.  (3)  that supernatants obtained from 
short-term cultures of histoincompatible mouse spleen cells  contained a  non- 
antigen-specific biologically active mediator capable of markedly affecting in 
vitro antibody responses to thymus-dependent antigens provided evidence for 
the existence of such a possible mediator participating in T-B-cell cooperation. 
In the succeeding 3 yr, these basic findings have been confirmed and extended 
in several ways. First, it has been also shown that other means of lymphocyte 
activation, such as exposure  to specific  antigen or nonspecific mitogens, also 
generate nonantigen-specific biologically active mediators capable of variably 
influencing B- and/or T-cell responses in vitro (4-21). Second, there have been 
reports  that  another  type of biologically active  lymphocyte factor(s)  which 
has  antigen  specificity can  be  generated  and  recovered  from  culture  super- 
natants in certain systems (9, 22-26).  It is not yet clear whether two distinct 
active  moieties,  one  nonspecific  and  the  other  antigen  specific,  participate 
together or in selected circumstances in the development of antibody responses. 
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The  present  experiments have  focused  on  the  biological and  biochemical 
properties of  a  nonspecific mediator produced by  populations of activated T 
lymphocytes during short-term in vitro reactions with foreign alloantigens. We 
have  analyzed the  activity  of  the  unseparated  and  of  chromatographically 
separated  fractions  of  the  supernatants from  such  cultures  on  the  in vitro 
responses  of  mouse  lymphocytes to  soluble 2,4-dinitrophenyl (DNP)-carrier 
conjugates  and  also  to  heterologous  erythrocytes.  The  results  demonstrate 
that  a  highly active protein moiety in the mol  wt  range of 30,000-40,000  is 
capable of  acting directly on B  lymphocytes,  in the  presence of  antigen, to 
effect triggering and subsequent differentiation and proliferation to antibody- 
forming cells in vitro. The active molecule(s), although not manifesting speci- 
ficity for antigen, does exhibit some strain-specific properties suggesting a pos- 
sible relationship to antigens or other gene products coded in the major histo- 
compatibility gene complex. 
Materials  and Methods 
The proteins, hapten-carrier conjugates, and SRBC antigens were prepared and used in a 
manner identical to those described in our previous reports  (27-29). 
Animals and Immunizations.--Mice  of the inbred lines DBA/2, C3H, BALB/c, C57BL/6, 
and (DBA/2  X C3H)F1 hybrids  (C3D2 F1) were obtained from the Jackson Laboratories, 
Bar Harbor,  Maine. Mice were immunized at 2-3 mo of age intraperitoneally with 100 #g 
of DNP-protein  conjugates emulsified in complete Freund's adjuvant (Difco Laboratories, 
Detroit, Mich.) and were used as primed spleen cell donors 2-6 mo thereafter. Mice used for 
spleen cell donors in primary in vitro responses were 2-5 mo of age. Thymus cell donors for 
the preparation  of activated T cells were 6-8 wk of age, the recipients 10- to 12-wk old. 
Allogeneic  Supernatants.--Preparation  of allogeneic supernatants were induced in the fol- 
lowing way (14-16, 30) : DBA/2 thymus cells were activated against C3H histocompafibility 
antigens  by  injecting  irradiated  DBA/2  recipients  (600 R)  intravenously  with  1 X l0  T 
thymus cells from 5- to  8-wk old DBA/2 mice mixed with  1 X l0  T irradiated  (2,000 R) 
C3D2F1 spleen cells. The spleens of these recipient animals were removed after 8 days. The 
recovery of (activated) T cells was about 20% of the original inoculum. 1 X l0  T  activated T 
cells were cultured  together with 1 X l0  T irradiated (2,000 R) C3D2F1 spleen cells in 1 ml 
of culture medium (31, 32). Supernatants were harvested 24 h later.  It should be noted that 
this  procedure  virtually eliminates potential  contributions  from  B  lymphocytes  or  their 
specific antibodies to the supernatant. Pilot experiments performed to establish optimal con- 
ditions for induction of the most active supernatants in this way showed that: (a) fetal calf 
serum  (10%) was required in the medium; otherwise, supernatants were either frequently 
quite suppressive or only low in enhancing activity; and (b) culture periods exceeding 24 h 
markedly increased the amounts of inhibitory materials in the supernatants. Thus, all super- 
natants employed in the following experiments were derived from 24-h cultures with fetal 
calf serum-supplemented medium. These supernatants are referred to also as allogeneic effect 
factors  (AEF) 1 in this  publication.  All allogeneic supernatants  of identical  cultures  were 
~Ab3reviations used in this paper:  AEF, allogeneic effect factors, ASC, extract  of  Ascaris 
suum;  BGG, bovine gamma  globulin; BSA, bovine serum  albumin;  D-GL, copolymer of 
D-glutamic acid, D-lysine; DNP2.x-ASC, moles of DNP X  10  -~ per  mg of ASC  protein; 
DNP20-FTG  ,  moles of  DNP  per  mole of  F'),G;  DNP14-KLH  per  100,000 tool wt 
units of KLH; DNPs-OVA, moles of DNP per mole of OVA; PTG, fowl gamma globulin; 
KLH,  keyhole limpet  hemocyanin; MLC, mixed lymphocyte  cultures;  OVA, ovalbumin; 
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pooled, centrifuged for 15 min at 1,500 g to remove the cells,  and filtered through a 0.45 #g 
Millipore filter  (Millipore Corp.,  Bedford,  Mass.).  They were  then  distributed  into  small 
aliquots and kept frozen at --20°C. 
Purification and  Chromatography of  the  AEF.-- 
Sephadex gel chromatography:  1.5-2.0 ml of 10-fold-concentrated allogeneic supernatant 
(UM-2 Ultrafiltration Membranes, Amicon Corp., Lexington, Mass.)  or, for control, of 10% 
fetal calf serum-containing medium were applied to a  Sephadex G-200  column (Pharmacia 
Fine Chemicals,  Inc.,  Uppsala,  Sweden)  (2.5  ×  90 cm) which was equilibrated with phos- 
phate-buffered  saline  (PBS).  All chromatography  procedures  were done at 4°C  and  under 
semisterile conditions using sterile endotoxin-free solutions  of PBS for prewashing  the gel 
and for elution at a  flow rate of 11  ml/h. Individual fractions were pooled as indicated in 
Results  (Fig. 4)  and concentrated  to the original volume with, according to the molecular 
weight range, the appropriate ultrafiltration membranes (UM-2 or PM-10). They were steri- 
lized by filtration through 0.45 #g Millipore filters and kept frozen. 
Pooled and concentrated biologically active fractions were rechromatographed on a Sepha- 
dex G100 column (2.5  X  90 era) in PBS at a flow rate of 18 ml/h. The column was calibrated 
using bovine  gamma  globufin  (BGG)  (mol  wt,  150,000),  bovine  serum  albumin  (BSA) 
(tool wt,  65,000),  and bovine pancreatic insulin (tool wt, 36,000 in associated form under salt 
and pH conditions employed) as markers.  Fractions were concentrated to the original vol- 
ume. 
Heat treatment:  Sensitivity of the AEF against heat was tested using the complete super- 
natant  and incubating  1-ml  aliquots in a  56°C  waterbath  for  1 h. 
Trypsin digestion:  Digestion was performed using the complete allogeneic supernatant 
and  10%  of  thoroughly  washed  agarose-coupled  trypsin  (Enzite  Agarose Trypsin,  Miles- 
Servac, England) for 10 h at 37°C. The supernatant was used afterwards as a 1:5 dilution for 
cell culture. 
Depletion of T Lymphocytes.--The preparation  of anti-0-serum,  determination of anti-0- 
serum cytotoxicity, and anti-0-serum treatment of spleen cells have been previously described 
(33). 
Spleen Cell Cultures and Determination of In  Vitro Antibody Responses.--The  Mishell- 
Dutton system  (31, 32)  was used with modification for culturing cells in microcultures de- 
scribed previously (27). Briefly, cultures were set up in a total volume of 0.3 ml in three steps 
antigen, AEF (or plain medium in appropriate controls), and cells were added to the culture 
wells in this order. Cell harvesting and assays for anfi-DNP and anti-SRBC plaque-forming 
cells (PFC) were performed as previously described  (27). 
Preparation  of  Antigen-Bound Macrophages.--Induction and  harvesting  of  peritoneal 
macrophages from unprimed mice were carried out as detailed in previous reports  (34, 35). 
Uptake  of antigen was  performed  by  exposing  2.5  X  l0 s  macrophages  to 4  #g  of  DNPo 
protein (in a total volume of 1.4 ml) for 30 m~n on ice; the cells were then washed thoroughly 
and resuspended in medium at a  concentration of 2.5  X  105 macrophages/ml.  Under these 
conditions the percent uptake  of  DNP-protein  ranged  from  0.25  to  0.35  (35).  100  #1  of 
these cells (2.5 ×  104 cells)  were added to each culture well as the only  source of  antigen. 
Macrophages incubated  without antigen served as background  controls.  The optimal dose 
of macrophages of 2.5  X  104/culture was established in pilot experiments.  This  number  of 
macrophages  contained  about  0.125-0.175  #g  of  DNP-protein.  The  cell  density  of the 
spleen cells in these cultures was 1.67 X  106 cells/ml. 
RESULTS 
Reconstitution  of  Helper  Cell  Function  in  Primary  In  Vitro  Anti-SRBC 
Antibody Responses by AEF.--Fig.  1 demonstrates  the strong  activity of AEF 
generated in supernatants  from 24 h  one-way MLC  reactions between DBA/2 
activated T  cells and heavily irradiated  C3D2FI target  spleen cells on the pri- 22  PROPERTIES  OF  ALLOGENEIC  EFFECT  FACTOR 
FIG. 1. Generation of allogeneic supernatant activity from 24 h one-way MLC reactions 
between DBA/2-activated T cells and heavily irradiated C3D2F1 target spleen cells. Un- 
treated and anti-0-serum-treated spleen cells from unprimed DBA/2 mice  were cultured with- 
out or with SRBC in the presence of various concentrations of supernatant as indicated. The 
primary IgM anti-SRBC antibody responses after 4 days are shown. 
mary in vitro IgM anti-SRBC antibody response of either untreated or anti-0- 
serum-treated  DBA/2 spleen  cells.  The following results  are  remarkable:  (a) 
AEF  enhanced  the  antigen-independent  background  as  well  as  the  antigen- 
dependent response  of untreated  spleen  cells;  (b)  The AEF reconstituted  the 
helper  cell  function of the  T-cell-depleted  cell  population  proportionately to 
the concentration of supernatant added; (c) The increase in PFC response from 
6,630  for the untreated  cells  to  11,080  for the  T-cell-depleted cultures  corre- 
sponds  to  the  enrichment  of  B  cells  by the  anti-0-serum  treatment  (killing 
rate was about 45 %). The IgG anti-SRBC response (not shown) paralleled the 
IgM response. 
Reconstitution  of  Helper  Cell Function  in  Secondary  In  Vitro  Anti-DNP 
Antibody  Responses by AEF.--The effects  of AEF on secondary IgG anti-DNP 
responses to DNP-keyhole limpet hemocyanin (KLH)  of untreated  and anti- 
0-serum treated spleen cells from DNP-KLH-primed DBA/2 donors are shown 
in Fig. 2. Effects on IgM responses (not shown) were parallel.  The addition of 
AEF resulted  in moderate enhancement of the secondary anti-DNP response DIETER ARMERDING AND DAVID H.  KATZ  23 
Fro.  2.  Reconsfitution  of helper cell function  in secondary in vitro  anti-DNP antibody 
responses by allogeneic effect factors.  Untreated  and  anti-0-serum-treated  spleen cells from 
DNP-KLH-primed  (4 too)  DBA/2 mice were cultured  (cell density  3.33 X  106 cells/ml) 
with or without DNP-KLH (1 /zg/ml) in the presence or absence of 20% allogeneic super- 
natant as indicated.  The IgG anti-DNP antibody responses after  4 days are shown. 
of  untreated  ceils  to  DNP-KLH  in  both  experiments.  In  exp.  1,  AEF  also 
induced a  considerable increase in the number of background anti-DNP  PFC. 
Again, the addition of AEF reconstituted  helper cell function in T-cell-depleted 
cultures,  but  no  appreciable  B-cell  enrichment  effect  was  observed. 
The Capacity of AEF to Bypass the Requirement for Carrier-Specific Helper 
T Cells in Secondary In Vitro Anti-DNP Antibody Responses.--The possibility 
that AEF may actually replace T-cell functions and act directly on B  lympho- 
cytes was tested by culturing  DNP-KLH-primed DBA/2 spleen  cells with  or 
without AEF and with  either the homologous conjugate, DNP-KLH, or vari- 
ous  heterologous  conjugates  (DNP-ovalbumin[OVA],  DNP-Ascaris[ASC], 
DNP-fowl gamma globulin[FyG], and DNP-D-glutamic acid, D-lysine[n-GL]) as 
soluble in vitro antigens. The data (IgG responses)  from four such experiments 
are summarized in Table I. These experiments point out the variability of re- 
sults obtained in this system in certain conditions.  In the absence of AEF, the 
consistent observations in all such cultures was the strong secondary response to 24  PROPERTIES  OF  ALLOGENEIC  EFFECT  FACTOR 
TABLE I 
Effect of A EF on Secondary  In Vitro A nti-DNP PFC Responses  to Heterologous DNP-Carrier 
Conjugates* 
Exp.  In vitro antigen 
lgG anti-DNP antibody response 
No AEF  AEF (20%) 
None  67  320 
DNP-KLH  1,950  2,610 
DNP-OVA  40  200 
DNP-ASC  0  300 
4a 
4b 
None  618  480 
DNP-KLH  3,658  3,927 
DNP-OVA  518  528 
DNP-F'yG  384  1,386 
DNP-D-GL  568  1,584 
None  100  334 
DNP-KLH  2,700  2,520 
DNP-OVA  66  1,504 
DNP-F3~G  34  1,570 
None  0  186 
DNP-KLH  1,860  3,000 
DNP-F3,G  80  213 
None +  M$~  53  213 
DNP-KLH-M~b bound*  1,320  1,860 
DNP-FTG-M  $ bound*  186  2,155 
*  DNP-KLH primed DBA/2 spleen cells were cultured at a density of 1.67 X  l0 s cells/ml 
for 4 days with or without antigen (1 #g/ml), in the presence or absence of AEF (20%). 
Anti-DNP PFC/107  cultured cells are given. Donors were 3.5-4 mo primed. 
:~ 2.5  X  104 macrophages  with or without antigen bound were added to each culture. 
DNP-KLH  and the failure of such cells to respond to any of the heterologous 
conjugates. The addition of AEF to cultures, however, resulted at times in de- 
velopment of secondary responses to heterologous DNP-carriers (cf. DNP-F'yG 
and DNP-D-GL in exp. 2, DNP-OVA and DNP-F3,G in exp. 3), and at times 
had no demonstrable effect on such responses (cf. DNP-OVA and DNP-ASC in 
exp.  1, DNP-OVA in exp. 2, and DNP-F~,G in exp. 4  a). The  IgM  responses 
paralleled the IgG responses in these experiments. 
The  variable  activity  of  AEF  on  responses  to  heterologous  DNP-carrier 
conjugates might be related to the form in which the specific determinants are 
presented  to  the  B  cell,  and  it  is  conceivable  that  this  may  vary  from  one 
primed  cell  preparation  to  another.  Such  a  variable  could  be  the  relative 
amounts of cell-bound vs. free antigenic determinants which exists in any given 
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where the addition  of AEF failed to stimulate  a  secondary response  to DNP- 
F'yG added to cultures  in free solution  (exp.  4  a)  but resulted  in an  excellent 
response  to macrophage-bound DNP-F3,G  (Exp.  4  b).  Note as well  the excel- 
lent response to macrophage-bound DNP-KLH. A  second experiment  is sum- 
marized in  Fig. 3  where,  again,  the  presence of AEF markedly enhanced  the 
secondary  response  to  macrophage-bound  as  contrasted  to  free  DNP-F3'G. 
Fro. 3. The capacity of AEF to bypass the requirement  for carrier-specific helper T cells 
in secondary in vitro anti-DNP antibody responses. Spleen cells from DNP-KLH-primed (4 
mo) DBA/2 mice were cultured at a cell density of 1.67 ×  106 cells/ml with orwithout antigen 
in the presence or absence of 10% allogeneic supernatant as indicated.  Soluble DNP-KLH 
or DNP-F3~G were added at a concentration of 1 #g/ml (cultures I, II, and V). Macrophage- 
bound antigen was added on 2.5 X  104 macrophages/well (cultures III, IV, and V). The IgG 
anti-DNP responses after  4 days are shown. Background  values for nonantigen-stimulated 
control cultures have been subtracted from each corresponding experimental value for purposes 
of clarity. 
More  importantly,  in  view  of the  possibilities  considered  above,  addition  of 
free  soluble  antigen  to  cultures  containing  macrophage-bound  DNP-F'rG 
completely  abolished  the  AEF-enhanced  secondary  response  to  DNP-F3,G. 
These  data  therefore  demonstrate,  the  importance  of  the  structural  form  in 
which  determinants  are  presented  to  B  cells  in  order  to  observe  enhancing 
activity of AEF. 
Partial Biochemical Characterization  of the AEF.--In  a  first series of experi- 
ments,  crude supernatants  were treated  in several  ways as shown in Table II 
and then tested for activity in anti-SRBC responses.  The results  clearly show 26  PROPERTIES  OF ALLOGENEIC  EFFECT  FACTOR 
TABLE  II 
Properties of the AEF: Enhancement of the In Vitro Primary Anti-SRBC Response and Re- 
constitution  of Helper  Cell Function  with  Various  Preparations  of AEF* 
Culture  Treatment of AEF  In vitro  antigen 
Anti-SRBC antibody response 
Untreated cells  Anti-8-serum-treated cells 
IgM-PFC  IgG-PFC  IgM-PFC  IgG-PFC 
1  No AEF  None  0  0  0  0 
SRBC  320  520  40  60 
2  Untreated  AEF (20%)  None  80  20  680  520 
SRBC  2,560  2,080  3,480  3,040 
Heated AEF (t h  None  48  33  184  167 
56°C)  SRBC  1,155  825  600  390 
4  Trypsin-digested  AEF  None  17  0  0  27 
SRBC  280  100  1,120  200 
* Unprimed, untreated,  or anti-0-serum-treated  DBA/2 spleen cells were cultured with or 
without SRBC  (1%)  for 4 days in  the presence or absence of allogeneic supernate  (20%) 
which was previously treated  in the manner indicated.  Anti-SRBC PFC/107 cultured  cells 
are given. 
that both activities of AEF, namely, the enhancing effect on the in vitro PFC 
response of untreated  lymphocytes to SRBC  and  the capacity to reconstitute 
helper  cell  function  in  cultures  of  anti-0-serum-treated  cells  are  sensitive  to 
heating  for  1 h  at 56°C  and  to digestion  with  trypsin. 
The  allogeneic  supernatants  were  next  subjected  to  repeated  chromato- 
graphic separation on Sephadex G-200 and G-100 and the various eluent frac- 
tions tested for activity. The experiments depicted in Figs. 4  and 5  show that 
the biological activity of the AEF is associated with a molecule of homogeneous 
shape and size, as evidenced by the fact that the active moiety elutes in a well- 
defined,  albeit small, peak on both gel beds (cf. Fraction V  in Fig. 4 and Frac- 
tion B in Fig. 5). If the AEF are globular proteins, the mol wt is in the range of 
30,000-40,000  since activity coincides most nearly with the position of insulin 
on  G-100  (Fig.  5).  Further  calibration  of  this  column  demonstrated  defined 
peaks  for chymotrypsinogen A  (tool  wt  25,000)  and  ribonuclease  A  (tool  wt 
13,700)  separating  in subsequent  fractions from the  gel bed  (not shown). 
Activity  of the AEF  on  In  Vitro  Antibody  Responses  of Cells from  Various 
Mouse Strains.--The  biological activity of the AEF requires  that it  interacts 
with  either:  (a)  the  antigen,  (b)  at  least  one,  and perhaps  more,  of the  cells 
participating in the induction of an antibody response, or (c) with both antigen 
and  responding  cell(s).  This  assumption  implies  that  the  AEF  might  have 
specificity for either  the antigen or for one or more of the involved cell types. 
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FIG. 4.  Comparison  of activities of unseparated and  Sephadex  G-200-fractionated  AEF 
on  primary  anti-SRBC  responses  of  untreated  and  anti-0-serum-treated  DBA/2  spleen 
cells. The chromatography elution patterns of normal culture medium and allogeneic super- 
natant on Sephadex G-200 are illustrated on the far left. The responses of untreated (top two 
groups)  and anti-0-serum-treated cells in the presence of equal concentrations (50% in refer- 
ence to the original unseparated supernatant) of various fractions of the G-200 eluent and a 
50%  concentration of unseparated supernatant,  as indicated, were  determined. The  IgM 
anti-SRBC PFC after 4 days in the absence or presence of SRBC  are shown. 
the  crude  AEF  prepared  by  reacting  DBA/2  activated  T  cells  with  target 
C3D2F1  cells and testing its activity on the secondary anti-DNP  responses of 
untreated and anti-0-serum-treated DNP-KLH-primed spleen cells from DBA/ 
2,  C3H,  (C3D2)F1,  and  BALB/c  mice.  As shown  in  Table  III,  AEF  almost 
fully reconstituted helper function in  responses of the T-cell-depleted DBA/2 
and  (C3D2)FI populations; in addition, AEF markedly increased  background 
PFC  and the secondary response of untreated  cells to DNP-KLH  in cultures 
of (C3D2)F1  cells. The activity of AEF on cells from C3H  mice was consider- 
ably less, whereas the response of untreated BALB/c cells to DNP-KLH  was, 
in  fact,  suppressed  by  the  presence  of  AEF  at  the  concentration  employed 
(20 %). This suppressive effect of unpurified AEF was observed over a  concen- 
tration range down to 2.5 %  (not shown). 
These  data  indicate  either  that  crude  AEF  contains  an  inhibitory moiety 28  PROPERTIES  OF  ALLOGENE~  EFFECT  FACTOR 
FI6. 5. Fractions IV and V from G-200 (see Fig. 4) were pooled and subjected to further 
chromatography on G-100. The elution patterns  of this supernatant  and the corresponding 
markers BGG (tool wt 150,000), BSA (tool wt 65,000), and insulin (tool wt 36,000 in hexa- 
merle form) are shown on the far left. The primary IgM anti-SRBC responses of untreated 
and anti-0-serum-treated DBA/2 cells in the presence of the various fractions indicated (50% 
concentration in reference to the  original unseparated supernatant)  are shown. 
that acts on BALB/c but not on DBA/2 spleen cells, or, alternatively, a mix- 
ture of distinct moieties having, respectively, enhancing and inhibitory activi- 
ties  and  that  the  enhancing  factor acts best on DBA/2  while  the  inhibitory 
factor  acts  preferentially  on  BALB/c  cells.  We  attempted  to  dissect  these 
possibilities by comparing the activities of crude AEF  and active G-200 chro- 
matographic fractions of AEF on the primary anti-SRBC  responses of spleen 
cells  from DBA/2,  C3H,  BALB/c,  and  C57BL/6  mice.  As  shown  in  Table 
IV,  unpurified  AEF  (10%)  had  the  effect of:  (a)  enhancing  the  response  of 
untreated  and reconstituting  (with enrichment)  the response of anti-e-treated 
DBA/2 cells; (b) not influencing the  response of untreated  C3H cells;  and  (c) 
suppressing  the  responses  of untreated  and  not  reconstituting  the  responses 
of  anti-0-treated  cells  both  in  BALB/c  and  C57BL/6  strains.  The  addition 
of purified AEF  (2 %)  to  cultures  of these  same cells resulted  in  marked  in- 
creases in responses of all strains and,  particularly important, was capable  of 
fully reconstituting  BALB/c anti-0-treated  cells;  the  degree  of reconstitution 
with  C57BL/6 cells was, in  contrast,  only partial. 
DISCUSSION 
The  studies  presented  here  have  demonstrated  the  biological  and  certain 
biochemical properties of an active moiety produced in supernatants of short- 
term (24 h)  in vitro reactions between T  cells specifically activated to foreign 
alloantigens and  the  corresponding target cell population.  These experiments 
are based on previous results of in vivo (36,  37)  and in vitro  (38-40)  experi- 
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TABLE III 
Reconstitution of Helper Cell Function in Secondary In Vitro Anti-DNP Antibody Responses 
of Various Mouse Strains with AEF* 
Exp.  Strain  Cells  In vitro antigen 
IgG anti-DNP response 
No AEF  AEF (2O%) 
1  DBA/2 
2  C3H 
3  (C3D2)Ft 
4  BALB/c 
Untreated  None  26  1,440 
DNP-KLH  3,400  3,780 
Anti-0-serum treated  None  146  68 
DNP-KLH  440  3,000 
Untreated  None  203  317 
DNP-KLH  1,000  1,680 
Anti-0-serum treated  None  160  239 
DNP-KLH  234  510 
Untreated  None  200  1,202 
DNP-KLH  2,760  4,500 
Anti-0-serum treated  None  26  1,320 
DNP-KLH  360  1,920 
Untreated  None  66  168 
DNP-KLH  5,400  2,400 
Anti-0-serum treated  None  80  360 
DNP-KLH  360  840 
*  DNP-KLH-primed, untreated,  or anti-0-serum-treated  spleen cells (cell density, 1.67 X 
106 cells/ml)  from various mouse strains were cultured  with or without DNP-KLH (1 /zg/ 
ml) in the absence or presence of AEF for 4 days. Figures presented are PFC/10  ~ cultured 
cells. Donors were primed 3 mo (exp. 1), 5 mo (exp. 2) and 3.5 mo (exp. 3 and 4). 
One of the questions to which we have addressed  our studies is whether an 
active  moiety  generated  in  vitro  behaves  in  a  virtually  identical  biological 
fashion as the phenomenon we termed the "allogeneic effect" operates in vivo 
(36, 41). One very pertinent  reason why this question should be asked is that, 
heretofore,  studies  with  allogeneic  supernatants  have been largely performed 
on in vitro responses to particulate antigens, such as heterologous erythrocytes 
or haptenated  erythrocytes, in which circumstances positive results have been 
rather  reproducibly  obtained  (3-5,  9-11,  13-16,  18,  41).  On  the  other hand, 
in the one previously published  study in which  the activity of allogeneic  cell 
supernatants  on in vitro responses to soluble DNP-carriers was examined,  the 
enhancing effect could only be observed on responses to a thymus-independent 
DNP-carrier (9). 
This  apparent  distinction  between  the  capacity  of  allogeneic  factors  to 
stimulate  B-cell  responses  to  particulate  but  not  soluble  antigens  has  been 
clarified  by  the  following  observations  in  the  present  study:  The  extent  to 
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TABLE IV 
Reconstitution of Helper Cell Function in Primary In  Vitro Anti-SRBC Antibody Responses 
of Various Mouse Strains with Unpurified and Sephadex G-2OO-Purified Altogeneie 
Effect Factors* 
In vitro  Culture  Strain  Ceils  antigen 
IgM anti-SRBC  response 
Unpurified  Purified  AEF 
No AEF  AEF (10%)  (2%) 
1  DBA/2 
2  C3H 
3  BALB/c 
4  C57BL/6 
Untreated  None  50  184  200 
SRBC  450  1,710  3,420 
Anti-0-serumtreated  None  50  167  351 
SRBC  60  3,930  6,180 
Untreated  None  67  67  412 
SRBC  300  340  1,200 
Anti-0-serum  treated  None  40  93  665 
SRBC  40  700  2,060 
Untreated  None  267  251  251 
SRBC  1,050  570  1,920 
Anti-0-serum  treated  None  13  186  519 
SRBC  60  300  2,730 
Untreated  None  468  134  268 
SRBC  1,200  300  2,400 
Anti-0-serum  treated  None  0  106  240 
SRBC  40  60  720 
* Normal, untreated, or anti-0-serum-treated spleen cells from various mouse strains (cell 
density, 1.67 X  106 cells/ml for C57BL, 3.33 X  10 s cells/ml for DBA/2 and BALB/c, and 
5 X  106 cells/ml for C3H)  were cultured with or without  SRBC  (1%)  in the absence  or 
presence of AEF for 4 days. Figures presented are PFC/107 cultured cells. 
of  secondary  anti-DNP  responses  to  heterologous  DNP-carriers  is  clearly 
determined by the form in which the specific DNP determinants are presented 
to the B  cell. Thus, the presence of AEF failed to stimulate responses of DNP- 
KLH-primed cells to  free  soluble DNP-F-yG but  elicited excellent secondary 
responses  to  the  same  conjugate  bound  to  macrophage  surface  membranes 
(Exp.  4,  Tabre  I  and  Fig.  3).  Moreover,  the  response  to  macrophage-bound 
DNP-FTG  in  the presence  of AEF was  totally abolished by addition of free 
soluble DNP-F-yG to the same culture. It appears, therefore, that the presence 
of a  sufficient quantity of free DNP-carrier molecules might render all or some 
of the DNP-specific B  cells refractory to the action of AEF or, for that matter, 
the product(s) of carrier-stimulated T  cells if the latter are in any way different 
from AEF. This conclusion is in keeping with earlier observations made in our 
laboratory in a  similar in vitro system (35). It is most probably for this reason 
that considerable variability was observed in the capacity of AEF to stimulate 
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hence,  primed  spleen  cell  populations  with  greater  quantities  of  cytophilic 
antibodies and/or high affinity B cells may bind relatively more antigen onto 
cell  surfaces capable  of triggering other lymphocytes than might occur in a 
different spleen  cell  population. 
Another point of concern in drawing an analogy between the mechanism of 
the allogeneic effect in vivo and the  activity of AEF  and similar factors in 
vitro is whether or not absolute proof exists as  to  the direct action of such 
factors on B  cells in vitro. This is not an inconsequential problem in validly 
interpreting any of these systems since it is possible for a  biologically active 
substance to rapidly expand and/or stimulate differentiation of small numbers 
of T  cells present in a  given cell population. A note of caution in this regard 
was raised previously by others (3, 5, 18). We have tested this possibility in the 
present studies by analyzing the capacity of AEF to stimulate B cells exposed 
to the DNP-D-GL copolymer. This compound has  been  demonstrated  to  be 
highly tolerogenic for DNP-specific B  cells  both in vivo and in vitro  under 
normal  circumstances  (29,  42-44).  However,  when  administered  to  appro- 
priately primed  animals during  a  critical  time period  after  induction of an 
allogeneic  effect,  DNP-D-GL  can  provide  a  definite  inductive  stimulus  for 
primary or secondary anti-DNP antibody responses (29, 41, 45, 46).  Since no 
demonstrable T-cell function specific  for the D-GL carrier  has been demon- 
strated,  these  observations  provided  the  strongest  indirect  proof  that  the 
allogeneic effect is mediated by a direct interaction on the responding B cells. 
The capacity of AEF to permit in vitro responses to DNP-D-GL in the present 
experiments (Table II) and a number of comparable experiments (not shown) 
constitutes conclusive evidence, therefore, that the active moiety involved is 
acting directly on B lymphocytes. 
The present experiments have demonstrated the following salient physico- 
chemical features of the active enhancing molecule in AEF: (a) it is a trypsin- 
sensitive protein; (b) it is labile to heating (56°C,  1 h), thereby indicating the 
importance of tertiary  structure  to  activity; and  (c)  it has a  mol wt in the 
range  of  30,000-40,000.  The  crude  supernatant  studied  here  consists  of  at 
least  two distinguishable activities, one enhancing and  the  other inhibitory. 
Inasmuch as the inhibitory activity can be largely removed by separatory gel 
chromatography, it  is  at least possible  to  state  that  some of the  inhibitory 
material is higher in molecular weight than the enhancing moiety. On the other 
hand,  it  has  not  yet  been  definitely established  that  the  active  enhancing 
fraction does not contain inhibitory as well as enhancing activity. Similarly, 
the existence of inhibitory and/or additional enhancing activities in the various 
higher molecular weight fractions must be established or ruled out by extensive 
analyses of the biological  activity of these fractions over broad dose ranges. 
Thus far, a variety of active supernatants have been described which differ 
in estimated mol wt from 27,000 to 300,000  (16,  18-20,  47).  It is possible that 
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which share  common biological properties.  However,  one possibility is  that 
certain of these factors are acting predominantly on T  cells and T-cell function 
and little, or not at all, on B  cells. This is virtually ruled out in the present 
studies by the capacity of AEF to stimulate B-cell  responses  to DNP-D-GL 
and  in  the  studies  of  Feldmann and  Basten  in  which  the  allogeneic factor 
enhanced anti-DNP responses of nude spleen cells to the T-cell4ndependent 
antigen DNP-flagellin (9). On the other hand, the systems used by Rubin and 
Coons (8,  12, 19) and Gorczynski et al. (7,  14, 16)  leave this possibility open 
since in the former case the activity of the factor has never been tested on T- 
cell-deprived spleen populations (8, 12, 19) and in the latter studies the active 
factor fails to stimulate B  cells in the absence of irradiated normal T  cells in 
the same culture  (7,  14,  16).  Another possible reason for differences may be 
related to aggregation of lower molecular weight molecules, before chromato- 
graphic procedures  employed, which could obscure  the validity of molecular 
weight  estimates. 
The  present  studies  have  also  questioned  whether  there  may be  genetic 
restrictions  governing  the  biological  activity  of  AEF.  Recent  observations 
demonstrating that most effective cooperative T-B-cell interactions occur when 
the respective cell populations possess  identical genes located within the/t-2 
gene complex led us to postulate the existence of a membrane "acceptor" site 
on  the  B-cell  surface  that  interacts  with  either  a  complementary molecule 
existing either as a T-cell surface site or as a product released from the T  cell 
(48-50). It occurred to us, therefore, that the active enhancing moiety in AEF 
might indeed represent  one such molecule and,  if so,  should manifest some 
relationship to histocompatibility specificities.  One might predict, for example, 
that the active enhancing molecule should act best or preferentially on B cells 
derived from the same histocompatibility type as the effector T  lymphocytes 
producing the molecules. 
The studies carried out by us  thus far,  and presented  here,  are  far from 
definitive in this regard. However, there is a  clear suggestion of the possible 
preferential activity of AEF on syngeneic B  lymphocytes. Thus, AEF from 
supernatants of mixed cultures  containing DBA/2  activated T  cells  and  ir- 
radiated  C3D2F1  target  cells  clearly  exhibited  the  greatest  enhancing  and 
reconstituting effects on B lymphocytes from DBA/2 and C3D2F1 mice, both 
of which possess  the DBA/2 (H-2  ~) histocompatibility molecules (Table III). 
The  purified AEF,  although  fully reconstituting  C3H  (H-2  k)  and  BALB/c 
(H-2  d) B-cell  responses, only partially reconstituted responses of B  cells from 
C57BL/6 mice (Table IV). It is not surprising to observe activity on the cells 
bearing the C3H haplotype since the target cells bearing such surface antigens 
might  also  release  active molecules with preferential  activity on  C3H  cells. 
Moreover, preliminary absorption studies with various spleen cell populations 
have demonstrated that spleen cells from normal DBA/2 mice are considerably 
more effective than cells of other strains in absorbing the biological enhancing 
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Although a considerable further analysis is essential to define the relationship 
of the active moiety of AEF to histocompatibility gene products, it is interest- 
ing to point out that heretofore unexplained enhancing activity in unstimulated 
culture  supernatants of syngeneic thymocytes or  splenic  lymphocytes (3,  6, 
11,  14)  may be  explained by this hypothesis. Thus,  in certain  conditions it 
would not be surprising to find sufficient shedding, either spontaneously or as a 
result of nonspecific stimulation in the culture medium, of a histocompatibility 
gene product normally present on the T-cell surface that might be capable of 
enhancing and/or reconstituting responses of other B cells. Furthermore, this 
hypothesis  explains  the  capacity  to  observe  "bystander"  effects  in  mixed 
culture in vitro since  in all such studies demonstrating this phenomenon, the 
responding bystander B-cell populations have been syngeneic or isologous with 
the effector T-cell population (3,  15, 38-40). 
In  summary, as  an  extension of our previously stated hypothesis on  this 
point (1, 35, 41, 49),  we envisage the following sequence involved in effective 
T-B-cell interactions: The antigen-activated T lymphocytes, in close proximity 
to the appropriate B cell, either engages direct contact at the specific acceptor 
site(s)  on the B-cell  surface and/or releases the active products  (AEF)  that 
have specific  complementarity for, and bind to, the specific  acceptor sites on 
the B lymphocyte. It is likely that the antigen-binding event on the specific 
B-cell  surface Ig receptors has already taken place before the relevant inter- 
action with the T  cell occurs. Perhaps one of the important consequences of 
the  antigen-binding event followed by  subsequent  movement,  capping,  and 
endocytosis of the  B-cell  surface immunoglobulin receptors  (51)  is to  either 
appropriately expose greater numbers of acceptor sites or even induce steric 
conformational changes in  the  acceptor molecule. This may explain in  part 
why various  maneuvers,  other  than  specific  antigen binding,  leading  to  Ig 
receptor movement result in a more highly responsive B-cell population (52). 
Likewise, it is more conceivable that the process of activation of the T  cell 
results in a  critical steric or structural alteration in the active moiety on its 
cell surface which allows it then  to  interact  with  the  B-cell  acceptor.  This 
mechanism  would  explain  the  discriminant  regulation  involved  in  normal 
immune responses since only those T  and B lymphocytes whose surface sites 
have been either appropriately exposed or structurally altered by activation 
events would be capable of successful interaction. We believe that the respective 
molecules on T  and B  cells governing the interaction between these cells  are 
products of a  gene or genes in the histocompatibility gene complex. Experi- 
ments designed to identify the molecular specificity of AEF and its correspond- 
ing binding site on the B cell should resolve this issue. 
SUMMARY 
The studies presented herein have focused on the biological and biochemical 
properties of a  nonspecific mediator produced by populations of activated T 
lymphocytes during short-term in vitro reactions with foreign alloantigens. We 34  PROPERTIES  OF  ALLOGENEIC  EFFECT  FACTOR 
have  analyzed  the  activity  of  the  unseparated  and  of  chromatographically 
separated  fractions  of  the  supernatants  from  such  cultures  on  the  in  vitro 
responses  of  mouse  lymphocytes  to  soluble  and  macrophage-bound  DNP- 
carrier conjugates and  also to particulate heterologous erythrocytes.  The  re- 
sults demonstrate that a highly active protein moiety, termed allogeneic effect 
factors  (AEF),  in  the  mol  wt  range  of  30,000-40,000,  is  capable  of  acting 
directly  on  B  lymphocytes,  in  the  presence  of  antigen,  probably  to  effect 
triggering and subsequent differentiation and proliferation to  antibody-forming 
cells in  vitro.  The  active  molecule,  although  not  manifesting  specificity for 
antigen,  does  exhibit  some  strain-specific  properties  suggesting  a  possible 
relationship to cell surface antigens or other gene products coded in the major 
histocompatibility  gene  complex. 
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